Zongqiu Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zongqiu Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hui Liu
Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China
1 shared publication - Hui Wang
Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China
1 shared publication - Jianyun Lu
Department for Infectious Diseases Control and Prevention, Guangzhou Center for Disease Control and Prevention, Guangzhou, China
1 shared publication - Kuibiao Li
Guangzhou Centre for Disease Control and Prevention, No. 1, Qide Rd, Jiahe, Baiyun, Guangzhou, 510440, China
1 shared publication - Lei Luo
Guangzhou Center for Disease Control and Prevention, Guangzhou, 510515, China
1 shared publication - Ming Wang
Guangzhou Center for Disease Control and Prevention
1 shared publication
Latest Publications
- Open Access
- 3 October 2016
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 534
Factors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China
Guangzhou reported its first laboratory-confirmed case of influenza A (H7N9) on January 10, 2014. A total of 25 cases were reported from the first wave of the epidemic until April 8, 2014. The fatality rate was much higher than in previous reports. The objective of the current work was to describe the clinical and epidemiological characteristics of A (H7N9) patients in Guangzhou and explore possible reasons for the high fatality rate. Clinical and epidemiological information regarding A (H7N9) cases in Guangzhou was collected through review of medical records and field research. Data regarding clinical and laboratory features, treatment, and outcomes were extracted. Of the 25 patients, 84 % (21/25) had one or more underlying diseases. Fifteen patients (60.0 %) developed moderate to severe acute respiratory distress syndrome (ARDS), and 14 (56 %) died of the ARDS or multiorgan failure. Patients with longer delay between onset of illness and initiation of oseltamivir treatment were more likely to develop ARDS. Elevated C-creative protein, aspartate aminotransferase, creatine kinase, and lymphocytopenia predicted a higher risk of developing ARDS. The presence of underlying diseases and clinical complications predicted poor clinical outcome. Early oseltamivir treatment was associated with a reduced risk of developing ARDS.
- 3 October 2016
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 534
Open AccessFactors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China
Guangzhou reported its first laboratory-confirmed case of influenza A (H7N9) on January 10, 2014. A total of 25 cases were reported from the first wave of the epidemic until April 8, 2014. The fatality rate was much higher than in previous reports. The objective of the current work was to describe the clinical and epidemiological characteristics of A (H7N9) patients in Guangzhou and explore possible reasons for the high fatality rate. Clinical and epidemiological information regarding A (H7N9) cases in Guangzhou was collected through review of medical records and field research. Data regarding clinical and laboratory features, treatment, and outcomes were extracted. Of the 25 patients, 84 % (21/25) had one or more underlying diseases. Fifteen patients (60.0 %) developed moderate to severe acute respiratory distress syndrome (ARDS), and 14 (56 %) died of the ARDS or multiorgan failure. Patients with longer delay between onset of illness and initiation of oseltamivir treatment were more likely to develop ARDS. Elevated C-creative protein, aspartate aminotransferase, creatine kinase, and lymphocytopenia predicted a higher risk of developing ARDS. The presence of underlying diseases and clinical complications predicted poor clinical outcome. Early oseltamivir treatment was associated with a reduced risk of developing ARDS.